We suggest that P2YR-mediated VEGFR-2 activation can promote tumour angiogenesis indirectly, as well as stimulate direct angiogenic effects on the endothelial cells where the original P2Y/VEGF signaling occurs. The gene discussed is KDR; the disease is neoplasm.